Overview
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 35 days for 2021). 5 of 6 audited by a statutory auditor.
- 202516/07/2026
- 202416/07/2025
- 202312/07/2024
- 202215/07/2023
- 202119/08/2022
- 202010/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
National Health Fund (NFZ) contracts
Js-Pharma has been an NFZ healthcare provider since 2024. In 2026 it is performing 3 contracts with a total value of USD 540.25. All its contracts were worth USD 2.22k in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Pilot programmes | wielkopolskie | 3 | USD 540.25 |
Authorized Representatives
Manner of representation
In dealings with external entities, including making declarations of will on its behalf and signing documents producing legal effects, each member of the management board is authorised to act independently, both in the case of a one-person management board and in the case of a multi-member management board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Janusz Józef Smolarekage 50 | 50 | $6,753.11 | 50% |
Krzysztof Rafał Szelcage 48 | 50 | $6,753.11 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2010-05-01.
58 1160 2202 0000 0001 6871 3994
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $56,151$56,151 |
Buildings and premises | $61,087$61,087 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 4, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $274.4K$274,373 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcyjno-Handlowe Apimexsp. z o.o. | $16,601,428.28 | apimex.pl | ||
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | ||
| Modrzewscysp. j. | $5,602,358.99 | aptekacentrum.lublin.pl | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl | ||
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | ||
| Rutkiewicz I Wspólnicysp. j. | – | aptekapoznan.com |
FAQ
Last updated: 2026-07-16